Acella's $46.5M Drug Recall Settlement Gets Initial Signoff
A Georgia federal judge on Wednesday gave preliminary approval of a nearly $46.5 million settlement from Acella Pharmaceuticals LLC to end a class action alleging the company sold worthless thyroid medication...To view the full article, register now.
Already a subscriber? Click here to view full article